Congenital portosystemic shunt
Congenital portosystemic shunt is a rare condition that is present at birth, in which blood vessels do not form properly in the liver. This condition can lead to serious health problems, such as liver damage and heart failure.
Overview[edit]
A congenital portosystemic shunt is a condition in which the blood vessels that normally carry blood from the intestines and spleen to the liver are either missing or malformed. This can cause blood to bypass the liver, leading to a buildup of toxins in the bloodstream.
Symptoms[edit]
Symptoms of congenital portosystemic shunt can vary widely, but may include:
- Jaundice (yellowing of the skin and eyes)
- Encephalopathy (brain disease, damage, or malfunction)
- Hepatomegaly (enlarged liver)
- Ascites (accumulation of fluid in the abdominal cavity)
Causes[edit]
The exact cause of congenital portosystemic shunt is unknown, but it is thought to occur during fetal development. It is not believed to be inherited.
Diagnosis[edit]
Diagnosis of congenital portosystemic shunt typically involves imaging tests, such as an ultrasound, CT scan, or MRI. A liver biopsy may also be performed.
Treatment[edit]
Treatment for congenital portosystemic shunt typically involves surgery to correct the abnormal blood vessels. In some cases, a liver transplant may be necessary.
Prognosis[edit]
The prognosis for individuals with congenital portosystemic shunt varies widely, depending on the severity of the condition and the individual's overall health.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
